Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Experimental Cell Research

• Publication date

  2014-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.yexcr.2014.01.024PMID 24518414PMCID PMC4043227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

  2013cited by this paper
• The Histone Deacetylase Inhibitor Sodium Butyrate Promotes Cell Death and Differentiation and Reduces Neurosphere Formation in Human Medulloblastoma Cells

  2013cited by this paper
• NeuroD1 regulation of migration accompanies the differential sensitivity of neuroendocrine carcinomas to TrkB inhibition

  2013cited by this paper
• Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1.

  2013cited by this paper
• Epigenetic and genetic features of 24 colon cancer cell lines

  2013influential reference
• DNA damage‐dependent NF‐κB activation: NEMO turns nuclear signaling inside out

  2012cited by this paper
• The Role of Nutraceuticals in Chemoprevention and Chemotherapy and Their Clinical Outcomes

  2011cited by this paper
• Clinical Epigenetics is now a fully open access journal

  2011cited by this paper
• Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β‐oxidation pathway

  2011cited by this paper
• Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.

  2011cited by this paper
• Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells

  2011cited by this paper
• Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining

  2010cited by this paper
• Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.

  2010cited by this paper
• Butyrate-Induced Cell Death and Differentiation Are Associated with Distinct Patterns of ROS in HT29-Derived Human Colon Cancer Cells

  2010cited by this paper
• Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.

  2009cited by this paper
• Whole brain radiotherapy with radiosensitizer for brain metastases

  2009cited by this paper
• Altered gene expression and miRNA expression associated with cancerous IEC-6 cell transformed by MNNG

  2009cited by this paper
• Inhibition of Histone Deacetylases Promotes Ubiquitin-Dependent Proteasomal Degradation of DNA Methyltransferase 1 in Human Breast Cancer Cells

  2008cited by this paper
• Genetic and epigenetic changes in colon cancer.

  2008cited by this paper
• [The effect of p21 on transcription of survivin in hepatocellular carcinoma HepG2 cells and its regulation mechanism].

  2008cited by this paper
• Regulation of gamma-H2AX and securin contribute to apoptosis by oxaliplatin via a p38 mitogen-activated protein kinase-dependent pathway in human colorectal cancer cells.

  2008cited by this paper
• Comparison of time trends in colon, rectum and anus cancer incidence (1973-2002) in Asia, from 'Cancer Incidence in Five Continents, Vols IV-IX'.

  2008cited by this paper
• Evaluation of the immunohistochemical stain patterns of survivin, Bak and Bag-1 in colorectal cancers and comparison with polyps situated in the colon.

  2008cited by this paper
• Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.

  2007cited by this paper
• DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES

  2006cited by this paper
• The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.

  2005cited by this paper
• Mechanisms for the Inhibition of DNA Methyltransferases by Tea Catechins and Bioflavonoids

  2005cited by this paper
• Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP

  2005cited by this paper
• An IAP in Action: The Multiple Roles of Survivin in Differentiation, Immunity and Malignancy

  2004cited by this paper
• Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice.

  2004cited by this paper
• Selective regulation of class I and class II histone deacetylases expression by inhibitors of histone deacetylases in cultured mouse neural cells.

  2004cited by this paper
• Inhibition of histone deacetylase activity by butyrate.

  2003cited by this paper
• Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon.

  2003cited by this paper
• SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities*

  2002cited by this paper
• Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit

  2001cited by this paper
• The p65 (RelA) Subunit of NF-κB Interacts with the Histone Deacetylase (HDAC) Corepressors HDAC1 and HDAC2 To Negatively Regulate Gene Expression

  2001cited by this paper
• Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis.

  2001cited by this paper
• Plasma and Tissue Levels of Tea Catechins in Rats and Mice During Chronic Consumption of Green Tea Polyphenols

  2000cited by this paper
• Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

  1998cited by this paper
• Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue.

  1998cited by this paper
• Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate.

  1998cited by this paper
• Butyrate stimulates cyclin D and p21 and inhibits cyclin-dependent kinase 2 expression in HT-29 colonic epithelial cells.

  1997cited by this paper
• Absorption, distribution, elimination of tea polyphenols in rats.

  1997cited by this paper
• Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells.

  1996cited by this paper
• Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.

  1996cited by this paper
• The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis?

  1996cited by this paper
• Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate

  1995cited by this paper
• Investigation of the role of G1/S cell cycle mediators in cellular senescence.

  1993cited by this paper
• Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53‐independent pathway: Implications for the possible role of dietary fibre in the prevention of large‐bowel cancer

  1993cited by this paper
• Effects of sodium butyrate and 5-azacytidine on DNA methylation in human tumor cell lines: variable response to drug treatment and withdrawal.

  1990cited by this paper
• Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts.

  1986cited by this paper

• Protein aggregation inhibitors induce divergent transcriptional responses in a cellular model of ɑ-synuclein seeded aggregation

  2026cites this paper
• Decoding HDACs and its inhibitors-artificial intelligence assisted smart software based super computational modelling technology in targeting cancer and neurological disorders of the brain

  2025cites this paper
• Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications

  2025cites this paper
• A Systematic Review of Food-Derived DNA Methyltransferase Modulators: Mechanistic Insights and Perspectives for Healthy Aging

  2025influential citation
• Modulation of NF-κB pathway in cancer therapy by sodium butyrate and Isoproterenol

  2025cites this paper
• Butyrate improves dextran sulfate sodium-induced imbalance of intestinal stem cell homeostasis in broilers

  2025cites this paper
• Lactobacillus gasseri prevents ibrutinib-associated atrial fibrillation through butyrate

  2025cites this paper
• Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms

  2025cites this paper
• Insights to therapeutic potentials, pharmaceutical formulations, chemistry and analytical methods of catechin

  2024cites this paper
• Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjects.

  2024cites this paper
• Opportunities and challenges of foodborne polyphenols applied to anti-aging health foods

  2024cites this paper
• Obesity-Associated Colorectal Cancer

  2024cites this paper
• The Postbiotic Properties of Butyrate in the Modulation of the Gut Microbiota: The Potential of Its Combination with Polyphenols and Dietary Fibers

  2024cites this paper
• Polyphenolic Compounds: Orchestrating Intestinal Microbiota Harmony during Aging

  2024cites this paper
• Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: Mechanisms insights and efficiencies.

  2024cites this paper
• XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis

  2024cites this paper
• Inhibition of Cancer Development by Natural Plant Polyphenols: Molecular Mechanisms

  2023cites this paper
• Improving the anti-tumor effect of EGCG in colorectal cancer cells by blocking EGCG-induced YAP activation.

  2023cites this paper
• Complexation of Apigenin and Oxymatrine Leading to Enhanced Anti-inflammatory Activity.

  2023cites this paper
• EGCG adjuvant chemotherapy: Current status and future perspectives.

  2023cites this paper
• Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products.

  2022cites this paper
• Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.

  2022cites this paper
• Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates

  2022cites this paper
• Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy

  2022cites this paper
• Epigallocatechin 3-gallate: From green tea to cancer therapeutics.

  2022cites this paper
• The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions

  2022cites this paper
• Sodium butyrate inhibits high glucose-induced inflammation by controlling the acetylation of NF-κB p65 in human monocytes

  2022cites this paper
• Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways

  2022cites this paper
• Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells

  2022cites this paper
• Flavonoids overcome drug resistance to cancer chemotherapy by epigenetically modulating multiple mechanisms.

  2021cites this paper
• Epigenetic Basis of Polyphenols in Cancer Prevention and Therapy

  2021cites this paper
• Gastrointestinal Tumors: Phytochemical and Drug Combinations Targeting the Hallmarks of Cancer

  2021cites this paper
• Targeting cellular senescence in cancer by plant secondary metabolites: A systematic review.

  2021cites this paper
• Nutrients and phytonutrients as promising epigenetic nutraceuticals

  2021cites this paper
• In situ delivery of biobutyrate by probiotic Escherichia coli for cancer therapy

  2021cites this paper
• Anticancer mechanisms of phytochemical compounds: focusing on epigenetic targets

  2021cites this paper
• Butyrate and the Intestinal Epithelium: Modulation of Proliferation and Inflammation in Homeostasis and Disease

  2021cites this paper
• Defensin γ-thionin from Capsicum chinense improves butyrate cytotoxicity on human colon adenocarcinoma cell line Caco-2

  2021cites this paper
• Defensin c-thionin from Capsicum chinense improves butyrate cytotoxicity on human colon adenocarcinoma cell line Caco-2

  2021cites this paper
• The Interplay between Diet, Gut Microbes, and Host Epigenetics in Health and Disease.

  2021cites this paper
• Inhibitory effect of sodium butyrate on colorectal cancer cells and construction of the related molecular network

  2021cites this paper
• A potential screening method for epigenetic drugs: uncovering stress-induced gene silencing in Chlamydomonas

  2021cites this paper
• Updated review on green tea polyphenol epigallocatechin-3-gallate as a cancer epigenetic regulator.

  2021cites this paper
• Functional Mechanisms of Green Tea Polyphenols and Their Molecular Targets in Prevention of Multiple Cancers

  2021cites this paper
• Mediterranean diet and health status: Active ingredients and pharmacological mechanisms

  2020cites this paper
• Non-Digestible Carbohydrate and the Risk of Colorectal Neoplasia: A Systematic Review

  2020cites this paper
• Assessment of the Therapeutic Potential of Epigallocatechin Gallate and/or Metformin on Oral Squamous Cell Carcinoma

  2020cites this paper
• Natural Polyphenols Targeting Senescence: A Novel Prevention and Therapy Strategy for Cancer

  2020cites this paper
• Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment

  2020cites this paper
• Relating the composition and interface interactions in the hard corona of gold nanoparticles to the induced response mechanisms in living cells.

  2020cites this paper
• Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer

  2020cites this paper
• Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease.

  2020cites this paper
• The Protective Effect of Polyphenols for Colorectal Cancer

  2020cites this paper
• Estrogenic biological activity and underlying molecular mechanisms of green tea constituents

  2020cites this paper
• The Role of Histone Acetylation and the Microbiome in Phytochemical Efficacy for Cardiovascular Diseases

  2020cites this paper
• Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease

  2020cites this paper
• Combination Cancer Chemoprevention by Targeting the Epigenome

  2020cites this paper
• Plasticity as a therapeutic target for improving cognition and behavior in Down syndrome.

  2020cites this paper
• Bioactive Polyphenols as Promising Natural Medicinal Agents Against Cancer: The Emerging Trends and Prospective Goals

  2020cites this paper
• The effects and mechanisms of epigallocatechin-3-gallate on reversing multidrug resistance in cancer

  2019cites this paper
• Combination Treatment of p53-Null HL-60 cells with Histone Deacetylase Inhibitors and Chlorambucil Augments Apoptosis and Increases BCL6 and p21 Gene Expression.

  2019cites this paper
• Epigenetic Mechanisms of Quercetin and Other Flavonoids in Cancer Therapy and Prevention

  2019cites this paper
• Epigenetics and the Microbiome

  2019cites this paper
• Effects of Intestinal Microbial–Elaborated Butyrate on Oncogenic Signaling Pathways

  2019cites this paper
• Polyphenols: Major regulators of key components of DNA damage response in cancer.

  2019cites this paper
• Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy

  2019cites this paper
• Cancer preventive and therapeutic effects of EGCG, the major polyphenol in green tea

  2018influential citation
• Intake of Plant Based Foods and Colorectal Cancer. A Case-Control Study in Romania

  2018cites this paper
• Effects of Starch-Entrapped Microsphere Supplementation on Metabolic Phenotype in C57BL/6J Mice

  2018cites this paper
• Molecular Targets of Epigallocatechin—Gallate (EGCG): A Special Focus on Signal Transduction and Cancer

  2018cites this paper
• Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved.

  2018cites this paper
• The Genetics and Epigenetics of Colorectal Cancer Health Disparity

  2018cites this paper
• Pterostilbene down‐regulates hTERT at physiological concentrations in breast cancer cells: Potentially through the inhibition of cMyc

  2018cites this paper
• The epigenetic modification during the induction of Foxp3 with sodium butyrate

  2018cites this paper
• Genomics-Driven Healthcare

  2018cites this paper
• Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review

  2018cites this paper
• Treponema denticola increases MMP‐2 expression and activation in the periodontium via reversible DNA and histone modifications

  2018cites this paper
• Fructooligosaccharide intake promotes epigenetic changes in the intestinal mucosa in growing and ageing rats

  2018cites this paper
• Epigenetic Patterns/Therapies Associated with Genetic Disorders

  2018cites this paper
• (−)‐Epigallocatechin‐3‐gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells

  2018cites this paper
• New Insights toward Colorectal Cancer Chemotherapy Using Natural Bioactive Compounds

  2017cites this paper
• Butyrate Inhibits Cancerous HCT116 Colon Cell Proliferation but to a Lesser Extent in Noncancerous NCM460 Colon Cells

  2017cites this paper
• Epigenetic Regulation of Gene Expression Induced by Butyrate in Colorectal Cancer: Involvement of MicroRNA

  2017cites this paper
• Targeting epigenome with dietary nutrients in cancer: Current advances and future challenges

  2017cites this paper
• Combination Epigenetic Therapy

  2017cites this paper
• Diet Factors in Cancer Risk

  2017cites this paper
• Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition

  2017cites this paper
• Histone Chaperone ASF1A Predicts Poor Outcomes for Patients With Gastrointestinal Cancer and Drives Cancer Progression by Stimulating Transcription of β-Catenin Target Genes

  2017cites this paper
• Nutrition in early life and developmental programming of chronic disease : focus on epigenetic mechanisms

  2017cites this paper
• Dietary polyphenols and chromatin remodeling

  2017cites this paper
• Green Tea and Its Extracts in Cancer Prevention and Treatment

  2017cites this paper
• Mediterranean Diet: Prevention of Colorectal Cancer

  2017cites this paper
• Short Chain Fatty Acids in the Colon and Peripheral Tissues: A Focus on Butyrate, Colon Cancer, Obesity and Insulin Resistance

  2017cites this paper
• Colorectal cancer and inflammatory bowel diseases: effects of diet and antioxidants.

  2017cites this paper
• Natural Polyphenols for Prevention and Treatment of Cancer

  2016cites this paper
• Urolithins, pomegranate ellagitannin microbial metabolites, as potential modulators of cell and molecular events associated with colorectal cancer: in vitro vs.: human studies= Potencial de las urolitinas, metabolitos microbianos derivados de los elagitaninos de la granada, como moduladores de proce

  2016cites this paper
• Natural Epigenetic-Modifying Molecules in Medical Therapy

  2016cites this paper
• Green tea mechanism of action in fighting different types of cancer

  2016cites this paper
• The Role of Sodium Phenylbutyrate in Modifying the Methylome of Breast Cancer Cells

  2016cites this paper
• A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells

  2016cites this paper